Oxidative Stress

Description

Oxidative stress arises when the production of reactive oxygen species (ROS) exceeds the cell's antioxidant capacity, leading to oxidative damage to lipids, proteins, and DNA. The brain is especially vulnerable: it consumes 20% of the body's oxygen, is enriched in oxidation-prone polyunsaturated fatty acids (PUFAs), contains high levels of redox-active iron, and has relatively modest antioxidant defenses compared to peripheral tissues. Glutathione (GSH), the brain's primary antioxidant, depends on cysteine import via the System Xc- antiporter.

In Alzheimer's disease, oxidative stress functions as both an early initiating event and a self-amplifying cascade. Mitochondrial electron transport chain dysfunction (particularly Complex IV/cytochrome oxidase deficiency) generates ROS through electron leakage. Environmental neurotoxicants -- including pesticides, heavy metals, and industrial chemicals -- converge on mitochondrial dysfunction as a molecular initiating event, cascading through oxidative stress to tau hyperphosphorylation and autophagic failure. Age-dependent iron accumulation fuels Fenton chemistry, generating hydroxyl radicals that attack membrane PUFAs. The resulting lipid peroxidation produces toxic aldehydes (4-HNE, MDA) that covalently modify critical proteins including the v-ATPase proton pump, creating a direct biochemical pathway from oxidative damage to lysosomal failure.

The oxytosis/ferroptosis pathway provides a unifying framework: GSH depletion via System Xc- inhibition inactivates GPX4, unleashing 12/15-lipoxygenase-mediated enzymatic peroxidation of arachidonic acid. This feeds forward through mitochondrial ROS amplification and store-operated calcium entry (via Orai1), ultimately triggering cell death. Nrf2-activating compounds (fisetin, CMS121, J147) that restore antioxidant gene expression represent a promising therapeutic direction.

Convergence Nodes

• Endosomal Nexus -- Oxidized lipids and proteins disrupt endosomal receptor trafficking
• APOE4 Hub -- APOE4's loss of disulfide bridge leaves PUFA cargo unprotected against peroxidation
• Compensatory Paradigm Nexus -- Abeta may initially function as an antioxidant response to lipid peroxidation

Prize Entrants

• Pamela Maher -- Developed the oxytosis/ferroptosis framework; identified the GSH-GPX4-4-HNE-v-ATPase pathway; discovered geroneuroprotective drug candidates
• Ashley Bush -- Linked age-dependent brain iron accumulation to ferroptotic oxidative stress; identified APP-ferroportin axis for iron efflux
• Erwin Roggen -- Mapped 27 environmental neurotoxicants converging on mitochondrial dysfunction and oxidative stress through Adverse Outcome Pathway framework
• Jeevan Pradhan -- Integrated oxidative stress into the "decryption model" of AD; proposed multi-target nutraceutical antioxidant therapy

External Scientists

• Brent Stockwell -- Ferroptosis pathway definition and GPX4 biology
• Scott Ayton -- Brain iron quantification and oxidative stress biomarkers

Key Open Questions

• Is oxidative stress primarily a consequence of mitochondrial aging, environmental exposure, or impaired antioxidant gene regulation (Nrf2 pathway)?
• Can antioxidant therapies succeed if targeted to specific subcellular compartments (mitochondria, lysosomes) rather than administered systemically?
• How does the temporal relationship between oxidative stress and amyloid/tau pathology differ between familial and sporadic AD?
• Can lipid peroxidation biomarkers (4-HNE, F2-isoprostanes) serve as preclinical AD markers?